Bath & Body Works came into this print trading like a problem stock, down over the past month and now slipping another 1.3% to about US$18.65 on the day. The headline from the quarter is not the share price. It is the earnings power that shows up in a roughly US$0.58 basic earnings per share on US$1.5b of revenue, with net income of US$118m.

For a retailer known for fragrance and body care, this quarter is really about profit quality. The immediate selloff reflects market expectations rather than what the income statement reports.

Love the earnings power Bath & Body Works just put up but wary of owning a retailer that might still behave like a problem stock in your portfolio? Take a look at our list of solid balance sheet and fundamentals stocks (51 results) for ideas that pair consistent profitability with stronger reported fundamentals.

Q2 2027 Earnings Summary

• Revenue Q2 2027 vs Q2 2026: US$1,514m vs US$1,549m (declined 2.3%)
• Net Income Q2 2027 vs Q2 2026: US$118m vs US$64m (up 84.4%)
• Basic EPS Q2 2027 vs Q2 2026: US$0.58 vs US$0.30 (up 91.7%)
• Trailing 12 month Basic EPS to Q2 2027 vs TTM to Q2 2026: US$3.86 vs US$3.40 (up 13.5%)

Prefer clean visual charts instead of another dense wall of earnings tables and footnotes? See Bath & Body Works' valuation picture in a simple, interactive format with the full company report for Bath & Body Works.

Bath & Body Works Turnaround: Proof Points, Not Just Promises

The bullish story on Bath & Body Works centers on a multi year turnaround that widens distribution, leans into recurring fragrance franchises and tightens costs. Q2 gives real proof points for that view. International and expanded distribution revenue rose 24.9%, with Amazon sales tripling sequentially and Ulta rolling out to roughly 600 stores. That directly supports the claim that new channels and global partnerships can broaden reach without relying solely on malls.

The bullish narrative also leans on digital and cost discipline. Direct sales grew 3% with better conversion, which aligns with the goal of a healthier omnichannel engine rather than just store traffic. Fuel for Growth savings are now expected to exceed the US$175m target by about US$25m, while adjusted SG&A is guided to a lower full year rate. That is a clear milestone for the margin improvement part of the thesis, even as headline revenue remains under pressure.

Compare Bath & Body Works' operational story with what institutions are signaling. See the consensus price target analysis for Bath & Body Works to check whether analysts think this turnaround thesis lines up with their targets.

Bath & Body Works Bears Still Have Ammo

The bearish view on Bath & Body Works is that a store-heavy model and rising cost pressures will cap growth and keep the turnaround in “show me” territory. The latest quarter does not fully disarm that argument. Net sales declined 2.3% and management still frames 2026 as an investment year, with full-year revenue guided to fall 4% to 2.5%. That is not the backdrop bears feared for a collapse, but it is also not the sales inflection they argued was missing.

Profit quality also leaves room for skepticism. Adjusted EPS of US$0.62 relies heavily on roughly US$80m of tariff refunds. Without that, earnings power would have been closer to US$0.31, and excluding the refund, gross margin would have compressed by about 90 bps. Bears worried that margin progress depends on one-offs and cost saves rather than healthier comp growth will see this as a milestone still missed.

With tariff refunds and cost cuts doing so much heavy lifting, it is fair to ask whether Bath & Body Works has deeper balance sheet or cash flow vulnerabilities that are not obvious from one quarter. Review the independent risk analysis for Bath & Body Works which shows 3 important warning signs to see if these margin questions are just the start of a wider risk pattern.

Stay Ahead With Bath & Body Works Insights

If Bath & Body Works' mix of earnings power, tariff refunds and cost saves has your attention, register for free with Simply Wall St and add it to your Watchlist to track share price moves against fair value estimates and watch for a more attractive entry point. Once you hold the stock, use the Portfolio Command Center to cut through noise and focus on the updates that matter most to your thesis. For a longer term view, lean on the Community to see how other investors are thinking about the same risks and catalysts you are weighing. That way you can spot hidden strengths or early warning signs sooner and keep a step ahead of the market.

Seeking Alternatives Beyond Bath & Body Works?

Fresh ideas move fast. Some stocks build quiet momentum, others are dropping into attractive ranges, and early research edge fades before the crowd catches up, so consider reviewing potential opportunities promptly.

• Spot income workhorses built around shareholder returns and scan the 12 dividend fortresses before these payouts are more widely reflected in prices.
• Explore the build-out of critical infrastructure and review the curated 38 power grid technology and infrastructure stocks while these grids and enablers are still less widely followed.
• Target real businesses behind the AI theme and work through the hand picked 74 profitable AI stocks that aren't just burning cash before momentum-focused traders revisit valuations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.